Otto Balsiger
@obalsiger.bsky.social
Director of Finance, Membership and Publishing at the British Society for Immunology (BSI), also Treasurer/Trustee of Applied Microbiology International (AMI). Dad who loves science and sports (especially #immunology and #taekwondo) All views are my own.
Reposted by Otto Balsiger
📢 UK clinical immunology teams! Applications are still open for the BSI-CIPN Clinical Audit Grant, funded by Grifols.
Up to £5,000 per project, funding awarded by March 2026.
Apply by 23 February 2026! https://bit.ly/49ULl3k
Up to £5,000 per project, funding awarded by March 2026.
Apply by 23 February 2026! https://bit.ly/49ULl3k
February 16, 2026 at 10:05 AM
📢 UK clinical immunology teams! Applications are still open for the BSI-CIPN Clinical Audit Grant, funded by Grifols.
Up to £5,000 per project, funding awarded by March 2026.
Apply by 23 February 2026! https://bit.ly/49ULl3k
Up to £5,000 per project, funding awarded by March 2026.
Apply by 23 February 2026! https://bit.ly/49ULl3k
Reposted by Otto Balsiger
📢 Special Collection CD40 turns 40: Four Decades of ‘Forty’-fying Immunotherapy🧬
Exploring 40 years of CD40/CD154 biology, therapeutics, and future directions across cancer, autoimmunity, transplantation & allergy.
Submissions open until March 2026: https://bit.ly/4rMo7lY
Exploring 40 years of CD40/CD154 biology, therapeutics, and future directions across cancer, autoimmunity, transplantation & allergy.
Submissions open until March 2026: https://bit.ly/4rMo7lY
February 13, 2026 at 5:03 PM
📢 Special Collection CD40 turns 40: Four Decades of ‘Forty’-fying Immunotherapy🧬
Exploring 40 years of CD40/CD154 biology, therapeutics, and future directions across cancer, autoimmunity, transplantation & allergy.
Submissions open until March 2026: https://bit.ly/4rMo7lY
Exploring 40 years of CD40/CD154 biology, therapeutics, and future directions across cancer, autoimmunity, transplantation & allergy.
Submissions open until March 2026: https://bit.ly/4rMo7lY
Reposted by Otto Balsiger
CASPASE‑8 supports T cell survival through mechanisms beyond repressing RIPK1‑dependent necroptosis. Conditional deletion studies reveal its essential role in CD8⁺ T cell maintenance and NKT cell development.
Read more: https://bit.ly/4r8Edqc
Read more: https://bit.ly/4r8Edqc
February 13, 2026 at 11:28 AM
CASPASE‑8 supports T cell survival through mechanisms beyond repressing RIPK1‑dependent necroptosis. Conditional deletion studies reveal its essential role in CD8⁺ T cell maintenance and NKT cell development.
Read more: https://bit.ly/4r8Edqc
Read more: https://bit.ly/4r8Edqc
So honoured to have been interviewed for the latest issue of Charity Finance
Otto Balsiger: ‘The four-day working week is a good way to support our teams’
Léa Legraien talks to Otto Balsiger, director of finance, membership and publishing at the British Society for Immunology...
www.linkedin.com
February 13, 2026 at 8:42 AM
So honoured to have been interviewed for the latest issue of Charity Finance
Reposted by Otto Balsiger
IFNγ from activated CD4⁺ T cells is a key driver of B‑cell differentiation and autoantibody production in IMQ‑induced lupus mice.
IFNγ deficiency dramatically reduced disease features, a promising immune pathway for future SLE therapies. https://bit.ly/4qs1hyZ
IFNγ deficiency dramatically reduced disease features, a promising immune pathway for future SLE therapies. https://bit.ly/4qs1hyZ
February 12, 2026 at 5:15 PM
IFNγ from activated CD4⁺ T cells is a key driver of B‑cell differentiation and autoantibody production in IMQ‑induced lupus mice.
IFNγ deficiency dramatically reduced disease features, a promising immune pathway for future SLE therapies. https://bit.ly/4qs1hyZ
IFNγ deficiency dramatically reduced disease features, a promising immune pathway for future SLE therapies. https://bit.ly/4qs1hyZ
Reposted by Otto Balsiger
New in Immunotherapy Advances: CD137 aptamer–shRNA chimeras show promise for targeting intratumoral Tregs. This approach downregulates key genes like EzH2 & Nrp1 in CD137⁺ Tregs and malignant cells, offering a potential new route for tumour immunotherapy.
🔗 https://bit.ly/4ad5S3o
🔗 https://bit.ly/4ad5S3o
February 12, 2026 at 4:43 PM
New in Immunotherapy Advances: CD137 aptamer–shRNA chimeras show promise for targeting intratumoral Tregs. This approach downregulates key genes like EzH2 & Nrp1 in CD137⁺ Tregs and malignant cells, offering a potential new route for tumour immunotherapy.
🔗 https://bit.ly/4ad5S3o
🔗 https://bit.ly/4ad5S3o
Reposted by Otto Balsiger
Highlighting this article that explores an alternative way of assessing mTOR inhibition therapy following kidney transplantation.
Read the article here: https://bit.ly/4kyQn9w
Read the article here: https://bit.ly/4kyQn9w
February 12, 2026 at 10:48 AM
Highlighting this article that explores an alternative way of assessing mTOR inhibition therapy following kidney transplantation.
Read the article here: https://bit.ly/4kyQn9w
Read the article here: https://bit.ly/4kyQn9w
Reposted by Otto Balsiger
🧬 New research shows lung basal cell–derived PROS1 reduces COVID‑19‑induced inflammation and enhances antigen presentation in monocytes.
Read the study: https://bit.ly/3MBrSMh
##COVID19Research #Immunology
Read the study: https://bit.ly/3MBrSMh
##COVID19Research #Immunology
February 12, 2026 at 5:07 PM
🧬 New research shows lung basal cell–derived PROS1 reduces COVID‑19‑induced inflammation and enhances antigen presentation in monocytes.
Read the study: https://bit.ly/3MBrSMh
##COVID19Research #Immunology
Read the study: https://bit.ly/3MBrSMh
##COVID19Research #Immunology
Reposted by Otto Balsiger
🌟 Interested in broadening your experience beyond academia?
The BSI Career Enhancing Grant can support internships in science communication and more. Applications are open until 25 March.
See how the grant could help you and apply here: https://bit.ly/3QedNDL
The BSI Career Enhancing Grant can support internships in science communication and more. Applications are open until 25 March.
See how the grant could help you and apply here: https://bit.ly/3QedNDL
February 12, 2026 at 2:15 PM
🌟 Interested in broadening your experience beyond academia?
The BSI Career Enhancing Grant can support internships in science communication and more. Applications are open until 25 March.
See how the grant could help you and apply here: https://bit.ly/3QedNDL
The BSI Career Enhancing Grant can support internships in science communication and more. Applications are open until 25 March.
See how the grant could help you and apply here: https://bit.ly/3QedNDL
Reposted by Otto Balsiger
🧬 Have you submitted your abstract for #UKimmunomet26? The deadline is approaching in 3 weeks!
Join the UK’s leading immunometabolism meeting in NCL for cutting edge research, international speakers & sessions for ECRs.
Find out more & register 🔗 https://bit.ly/493uE45
Join the UK’s leading immunometabolism meeting in NCL for cutting edge research, international speakers & sessions for ECRs.
Find out more & register 🔗 https://bit.ly/493uE45
February 12, 2026 at 10:00 AM
🧬 Have you submitted your abstract for #UKimmunomet26? The deadline is approaching in 3 weeks!
Join the UK’s leading immunometabolism meeting in NCL for cutting edge research, international speakers & sessions for ECRs.
Find out more & register 🔗 https://bit.ly/493uE45
Join the UK’s leading immunometabolism meeting in NCL for cutting edge research, international speakers & sessions for ECRs.
Find out more & register 🔗 https://bit.ly/493uE45
Reposted by Otto Balsiger
This #February11 we are celebrating Prof Jessica Teeling, winner of the BSI Public Engagement Award! Her grant‑supported “Snakes and Letters for a Healthy Brain” project is inspiring conversations on dementia risk + immunity. #WomenInScience
Read here: https://bit.ly/3Ktiito
Read here: https://bit.ly/3Ktiito
February 11, 2026 at 11:15 AM
This #February11 we are celebrating Prof Jessica Teeling, winner of the BSI Public Engagement Award! Her grant‑supported “Snakes and Letters for a Healthy Brain” project is inspiring conversations on dementia risk + immunity. #WomenInScience
Read here: https://bit.ly/3Ktiito
Read here: https://bit.ly/3Ktiito
Reposted by Otto Balsiger
Celebrating #February11 by highlighting Professor Claudia Mauri, the Editor‑in‑Chief of @ceijournal.bsky.social Her leadership and expertise continue to shape the future of immunology.
Read the interview on the BSI website here: https://bit.ly/4abuedR
##WomenInScience
Read the interview on the BSI website here: https://bit.ly/4abuedR
##WomenInScience
February 11, 2026 at 1:48 PM
Celebrating #February11 by highlighting Professor Claudia Mauri, the Editor‑in‑Chief of @ceijournal.bsky.social Her leadership and expertise continue to shape the future of immunology.
Read the interview on the BSI website here: https://bit.ly/4abuedR
##WomenInScience
Read the interview on the BSI website here: https://bit.ly/4abuedR
##WomenInScience
Reposted by Otto Balsiger
Marking #February11 by celebrating Professor Tracy Hussell, BSI President, and her Nature Mentoring Award for Lifetime Achievement.
A great recognition of her commitment to supporting early career researchers and strengthening the immunology community.
##WomenInScience #Immunology
A great recognition of her commitment to supporting early career researchers and strengthening the immunology community.
##WomenInScience #Immunology
February 11, 2026 at 4:14 PM
Marking #February11 by celebrating Professor Tracy Hussell, BSI President, and her Nature Mentoring Award for Lifetime Achievement.
A great recognition of her commitment to supporting early career researchers and strengthening the immunology community.
##WomenInScience #Immunology
A great recognition of her commitment to supporting early career researchers and strengthening the immunology community.
##WomenInScience #Immunology
Reposted by Otto Balsiger
📣 We’re delighted to see our latest African swine fever research featured on the @pirbrightinst.bsky.social blog
The study uncovers how ASFV rapidly disrupts the immune system in pigs, shedding new light on why the virus is so hard to control.
Read the blog 👉 https://bit.ly/4kn8bnK
The study uncovers how ASFV rapidly disrupts the immune system in pigs, shedding new light on why the virus is so hard to control.
Read the blog 👉 https://bit.ly/4kn8bnK
February 10, 2026 at 9:18 AM
📣 We’re delighted to see our latest African swine fever research featured on the @pirbrightinst.bsky.social blog
The study uncovers how ASFV rapidly disrupts the immune system in pigs, shedding new light on why the virus is so hard to control.
Read the blog 👉 https://bit.ly/4kn8bnK
The study uncovers how ASFV rapidly disrupts the immune system in pigs, shedding new light on why the virus is so hard to control.
Read the blog 👉 https://bit.ly/4kn8bnK
Reposted by Otto Balsiger
Great to chat with Joel Snape about all things sneezing. Great seeing comments from @cathnoakes.bsky.social too
The sneeze secret: how much should you worry about this explosive reflex?
It is one of the most powerful involuntary actions the human body can perform. But is a big sneeze a sign of illness, pollution or something else entirely?
www.theguardian.com
February 8, 2026 at 1:31 PM
Great to chat with Joel Snape about all things sneezing. Great seeing comments from @cathnoakes.bsky.social too
Reposted by Otto Balsiger
Our 'Flow cytometry: multiparameter design' course is back in May 2026. It's interactive, online and tailored for immunologists.
This is your chance to learn from 40 plus years of cytometry expertise!
Find out more & register before places run out: https://bit.ly/4qip05l
This is your chance to learn from 40 plus years of cytometry expertise!
Find out more & register before places run out: https://bit.ly/4qip05l
February 5, 2026 at 1:00 PM
Our 'Flow cytometry: multiparameter design' course is back in May 2026. It's interactive, online and tailored for immunologists.
This is your chance to learn from 40 plus years of cytometry expertise!
Find out more & register before places run out: https://bit.ly/4qip05l
This is your chance to learn from 40 plus years of cytometry expertise!
Find out more & register before places run out: https://bit.ly/4qip05l
Reposted by Otto Balsiger
This #WorldCancerDay, explore how bispecific T‑cell engagers (BiTEs) could strengthen T‑cell responses against solid tumours, and the challenges still holding them back.
Read the open access review: https://bit.ly/4291Ipg
#CancerResearch #Immunotherapy #BiTEs
Read the open access review: https://bit.ly/4291Ipg
#CancerResearch #Immunotherapy #BiTEs
February 4, 2026 at 6:07 PM
This #WorldCancerDay, explore how bispecific T‑cell engagers (BiTEs) could strengthen T‑cell responses against solid tumours, and the challenges still holding them back.
Read the open access review: https://bit.ly/4291Ipg
#CancerResearch #Immunotherapy #BiTEs
Read the open access review: https://bit.ly/4291Ipg
#CancerResearch #Immunotherapy #BiTEs
Reposted by Otto Balsiger
Our UK wide workforce report shows that training capacity for future immunology consultants varies sharply across the nations.
Some areas have very limited specialty registrar numbers, putting the future pipeline at risk and increasing long term pressure on services.
Some areas have very limited specialty registrar numbers, putting the future pipeline at risk and increasing long term pressure on services.
February 4, 2026 at 6:27 PM
Our UK wide workforce report shows that training capacity for future immunology consultants varies sharply across the nations.
Some areas have very limited specialty registrar numbers, putting the future pipeline at risk and increasing long term pressure on services.
Some areas have very limited specialty registrar numbers, putting the future pipeline at risk and increasing long term pressure on services.
Reposted by Otto Balsiger
This #WorldCancerDay, explore how boosting natural killer (NK) cell activity, from CAR‑NK therapies to NK‑cell engagers and checkpoint strategies, could strengthen our fight against cancer.
Read the open access review: https://bit.ly/4j8dKEW
#Immunotherapy #NKcells
Read the open access review: https://bit.ly/4j8dKEW
#Immunotherapy #NKcells
February 4, 2026 at 2:03 PM
This #WorldCancerDay, explore how boosting natural killer (NK) cell activity, from CAR‑NK therapies to NK‑cell engagers and checkpoint strategies, could strengthen our fight against cancer.
Read the open access review: https://bit.ly/4j8dKEW
#Immunotherapy #NKcells
Read the open access review: https://bit.ly/4j8dKEW
#Immunotherapy #NKcells
Reposted by Otto Balsiger
This #WorldCancerDay, explore how bispecific T‑cell engagers (BiTEs) could strengthen T‑cell responses against solid tumours, and the challenges still holding them back.
Read the open access review here: https://bit.ly/4291Ipg
#CancerResearch #Immunotherapy #BiTEs
Read the open access review here: https://bit.ly/4291Ipg
#CancerResearch #Immunotherapy #BiTEs
February 4, 2026 at 2:24 PM
This #WorldCancerDay, explore how bispecific T‑cell engagers (BiTEs) could strengthen T‑cell responses against solid tumours, and the challenges still holding them back.
Read the open access review here: https://bit.ly/4291Ipg
#CancerResearch #Immunotherapy #BiTEs
Read the open access review here: https://bit.ly/4291Ipg
#CancerResearch #Immunotherapy #BiTEs
Reposted by Otto Balsiger
Our 'Single cell and spatial omics' course is back in April 2026! The course is all live and online on Mondays, plus full self paced access.
Great value - 9.5 out of 10 rated by past attendees and BSI members save 50% on fees 👀
Register today: https://bit.ly/48GDDYL
Great value - 9.5 out of 10 rated by past attendees and BSI members save 50% on fees 👀
Register today: https://bit.ly/48GDDYL
February 4, 2026 at 10:00 AM
Our 'Single cell and spatial omics' course is back in April 2026! The course is all live and online on Mondays, plus full self paced access.
Great value - 9.5 out of 10 rated by past attendees and BSI members save 50% on fees 👀
Register today: https://bit.ly/48GDDYL
Great value - 9.5 out of 10 rated by past attendees and BSI members save 50% on fees 👀
Register today: https://bit.ly/48GDDYL
Looks like this is going to be another fascinating BSI meeting
🧬 How do we move immunosenescence research forward?
Join us in Guildford this May to explore next generation technologies for studying immune ageing.
The event is taking place on 20 and 21 May 2026. Submit an abstract and be part of the discussion! 🔗 https://bit.ly/3YGD7VW
Join us in Guildford this May to explore next generation technologies for studying immune ageing.
The event is taking place on 20 and 21 May 2026. Submit an abstract and be part of the discussion! 🔗 https://bit.ly/3YGD7VW
February 3, 2026 at 5:23 PM
Looks like this is going to be another fascinating BSI meeting
Reposted by Otto Balsiger
🎗️ Ahead of #WorldCancerDay, check out this review by Shania Makker, Charlotte Galley & Clare L Bennett exploring how advances in immunology and mRNA platforms are reshaping the future of therapeutic cancer vaccines.
Read the article: https://bit.ly/4cefxGm
Read the article: https://bit.ly/4cefxGm
February 3, 2026 at 4:54 PM
🎗️ Ahead of #WorldCancerDay, check out this review by Shania Makker, Charlotte Galley & Clare L Bennett exploring how advances in immunology and mRNA platforms are reshaping the future of therapeutic cancer vaccines.
Read the article: https://bit.ly/4cefxGm
Read the article: https://bit.ly/4cefxGm
Reposted by Otto Balsiger
🔬Maria Filika & Stergios Katsiougiannis explore how salivary gland epithelial cells in Sjögren’s syndrome actively drive and amplify autoimmune responses, reshaping how we view target tissues in autoimmunity.
Read the open access review: https://bit.ly/4k6LOTH
Read the open access review: https://bit.ly/4k6LOTH
February 2, 2026 at 10:10 AM
🔬Maria Filika & Stergios Katsiougiannis explore how salivary gland epithelial cells in Sjögren’s syndrome actively drive and amplify autoimmune responses, reshaping how we view target tissues in autoimmunity.
Read the open access review: https://bit.ly/4k6LOTH
Read the open access review: https://bit.ly/4k6LOTH
This is going to be a great meeting
📢 Calling immunologists across adaptive & innate immunity!
Abstract submission is open for the Oxford Immunology Symposium 2026, with a deadline of 18 February #OIS26
A great opportunity for cross disciplinary collaboration and networking in Oxford! 🔗 https://bit.ly/4qUY8bD
Abstract submission is open for the Oxford Immunology Symposium 2026, with a deadline of 18 February #OIS26
A great opportunity for cross disciplinary collaboration and networking in Oxford! 🔗 https://bit.ly/4qUY8bD
February 2, 2026 at 5:57 PM
This is going to be a great meeting